PODESTA GROUP, INC. for GENZYME

Budget/Appropriations BUD

House Concurrent Resolution 312 FY09 Budget Resolution Senate Concurrent Resolution 70 FY09 Budget Resolution LHHS Appropriations Comparative Effectiveness

Contacted: Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Neglected Disease Tax Credit H.R. 1424, Emergency Economic Stabilization Act of 2008

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA)

Bills named: H.R. 1424 (110th)

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007 S. 3600, Patent Reform Act of 2008 H R. 1908, Patent Reform Act of 2007

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ)

Bills named: S. 1145 (110th), S. 3600 (110th), H.R. 1908 (110th)

Medicare/Medicaid MMM

H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 3162, Children's Health and Medicare Protection Act of 2007 H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions H. R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions Comparative Effectiveness Lab demonstration issue H.R. 1424, Emergency Economic Stabilization Act of 2008 ESRD "bundling issues" and ESRD drug reimbursement issues MIPPA Technical Corrections

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ)

Bills named: S. 1376 (110th), H.R. 4 (110th), S. 3 (110th), H.R. 2606 (110th), H.R. 5480 (110th), H.R. 3162 (110th), S. 2662 (110th), H.R. 1424 (110th), S. 2029 (110th)

Pharmacy PHA

H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Neglected Disease Issues

Contacted: Food & Drug Administration (FDA); Executive Office of the President (EOP); SENATE; Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 4 (110th), S. 596 (110th), S. 1695 (110th), S. 623 (110th), H.R. 1956 (110th), H.R. 1038 (110th), S. 1505 (110th), H.R. 5629 (110th), S. 2029 (110th)